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A B S T R A C T   
Nitroreductases (NTRs), a family of flavin-containing enzymes, can be overexpressed in regions of tumor hyp-
oxia, i.e., areas deprived of oxygen. The detection of NTR may be applied for monitoring the hypoxia level in 
tumors. To quantify NTR, novel sensors were designed based on the conjugation of pyridazino-1,3a,6a- 
triazapentalene to a para-nitrophenyl, directly or with an alkyne linker, resulting in two probes denoted as 1- 
NO2 and 2-NO2. Both probes had a weak fluorescence (form off), while their reduction by NTR led to the over 15- 
fold enhancement of fluorescence intensity (form on) regardless of the oxygen concentration in their environ-
ment. The detection limit was as low as ca. 20− 30 ng/mL of NTR. Interestingly, the presence of human serum 
albumin significantly enhanced the observed fluorescence turned on by NTR in particular for the 2-NO2 probe. 
The in vitro response to both probes was evaluated on the highly metastatic human melanoma A2058 cell line, 
where NTR levels increased under hypoxic conditions. Their low toxicity, high photostability, and efficient 
uptake combined with a strong correlation between the enhancement of fluorescence and hypoxia in cells 
indicate the high potential of the 1-NO2 and 2-NO2 probes for the assessment of the hypoxic environment in 
biomedical research. The designed compounds allowed for a fast determination of the difference in NTR content 
of cells without the need for special sample preparation such as cell lysis. The changes can be monitored using a 
plate reader, flow cytometer, and fluorescence microscope, which that makes these probes a remarkably uni-
versal tool.   
1. Introduction 
Nitroreductases (NTRs) are a family of flavin-containing enzymes, 
which can reduce the nitroaromatic compounds using reduced NAD(P)H 
as an electron donor. NTRs take part in detoxification [1] however, the 
major interest in NTRs is related to using them to activate bioreductive 
prodrugs [2,3] or to evaluate the regions with low oxygen levels in tu-
mors, which are generally termed as hypoxia [4]. The existence of 
hypoxia within tumors and subsequent information about its relation 
and contribution to poor prognosis and treatment failure [5] provided a 
rationale for the development of tools helping in the evaluation of the 
hypoxia level. It was presumed that in cancer cells, hypoxia can promote 
overexpression of the reductive enzymes, such as NTRs, azoreductase, 
quinone reductase, cytochrome P450 reductase, xanthine oxidase, and 
others [6–8]. Despite the utilization of this feature for many years the 
relationship between the expression of these enzymes and the degree of 
hypoxia is largely unknown. To the best of our knowledge, the literature 
does not provide data on the direct quantification of selected enzymes in 
cells grown under normoxic vs hypoxic conditions. In this study, we 
demonstrate for the first time with a pyrazinotriazapentalene based 
probe that indeed there is an elevated level of NTR in highly metastatic 
human melanoma cells, line A2058, cultured under hypoxic conditions. 
This finding justifies our research focusing on new probes, that assess 
nitroreductase activity as potential markers for detection of hypoxia. 
Two types of NTRs are known. Type I, which is oxygen-insensitive 
and can catalyze reduction in the presence of molecular oxygen, and 
type II, which is oxygen-sensitive and only functions well under extreme 
hypoxia conditions [9,10]. Type I of NTRs conducts two-electron 
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reduction of the nitro moiety proceeding through the nitroso and hy-
droxylamine intermediates to the fully reduced amino adduct [10]. In 
type II of NTRs, a reaction can proceed via one-electron reduction, 
resulting in the formation of nitroaromatic anion-free radical in-
termediates [9], which in the presence of molecular oxygen can be 
re-oxidized with concomitant formation of superoxide anion radical. 
This leads to the consumption of reducing equivalents without a net 
reduction of the nitroaromatic substrate and is called a “futile cycle” 
[10]. However, in the absence of oxygen or in the presence of a low 
enough content, the reduction can proceed to the formation of the 
nitroso intermediate followed by the same steps as for type I NTR. Many 
of such oxygen-sensitive NTRs were described in mammalian systems 
[11] and they can be utilized to detect hypoxia via the determination of 
NTR activity. 
Over the last decade, many NTRs-sensitive small-molecule probes for 
NTR determination and for optical imaging of hypoxia were designed 
and tested in models as well as in living systems [4,12–15]. Most of the 
NTRs fluorescent probes relied on the attachment of a nitroaromatic 
moiety to a fluorophore which quenched its fluorescence, while the 
reduction of nitro moiety catalyzed by NTR resulted in an off-on 
fluorescence response. Some of the tested probes seemed to be very 
promising, though, despite many efforts, the transfer of research find-
ings into commercial use, as well as the accessibility of such probes to a 
wide range of researchers, is very limited. Therefore, a search for better 
probes for NTR determination is still an open issue. To contribute, we 
have designed an entirely new type of sensor by conjugating the 
pyridazino-1,3a,6a-triazapentalene (PyTAP, Chart 1 ) fluorophore 
(recently discovered by us [16,17]) to a nitrophenyl moiety, which 
resulted in obtaining compounds that exhibit weak fluorescence (form 
off), which become highly fluorescent (form on) upon the reduction by 
NTR under hypoxic conditions, as shown schematically in Chart 1 . A 
para-nitrophenyl responsive moiety conjugated to PyTAP either directly 
or with an alkyne linker gave two probes (see Scheme 1) denoted as 
1-NO2 and 2-NO2, as well as their reduced amine counterparts 1-NH2 
and 2-NH2. The response of both probes to NTRs was evaluated with the 
use of type I oxygen-insensitive NTR from Escherichia coli as well as type 
II oxygen-sensitive NTR using the mammal liver microsomes as its 
source (see Chart 1). Also, the impact of the interaction between 1-NO2 
and 2-NO2 NTR probes and human serum albumin (HSA) was investi-
gated. The in vitro evaluation of both probes as hypoxia markers related 
Chart 1. Schematic representation of the major outcomes of the investigated probes.  
Scheme 1. Preparation of 1-NO2, 1-NH2, 2-NO2, 2-NH2 compounds.  
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to the activity of NTRs was carried out on the highly metastatic human 
melanoma A2058 cell line. 
2. Material and methods 
2.1. Synthesis and characterization 
2.1.1. General chemistry 
Unless otherwise specified, all reagent-grade chemicals and solvents 
- commercially available, were used without further purification. 1H and 
13C NMR spectra were recorded on the Bruker Avance DPX-250 (250 
MHz) and Bruker Avance 400 (400 MHz) spectrometers, reporting 
chemical shifts (δ) in ppm and coupling constants (J) in Hz. Chemical 
shifts were analyzed in reference to the solvent peaks (DMSO-d6, CDCl3). 
High-resolution mass spectra (HRMS) were registered on a Bruker maXis 
mass spectrometer by the "Fédération de Recherche" ICOA/CBM 
(FR2708) platform. Low-resolution mass spectra were recorded on a 
Thermo Scientific Endura mass spectrometer. Thin-layer chromatog-
raphy (TLC) was performed with the use of aluminum sheets pre-coated 
Silica Gel 60 F254 (Merck), which were visualized with ultraviolet light 
at 254 nm. Purification of compounds included the column chroma-
tography on Silica Gel 60 (230− 400 mesh, Merck). Melting points were 
determined using Thermo Scientific 9200 apparatus with capillary 
tubes. The infrared spectra were recorded on a Thermo Scientific Nicolet 
iS10 FT-IR and maximum absorption wavenumbers ν" are given in cm− 1. 
Experimental details for the photophysical characterization (absorption 
and emission spectra, the quantum yield of luminescence (ϕ), the 
luminescence lifetime (τ) and photostability) are described in Support-
ing Information. 
Additionally, the synthesis of the substrate 1-ethynyl-4-nitrobenzene 
is presented in the Supporting Information section. Preparation of 
PyTAP is precisely described in M. Daniel et al. [16]. 
2.1.2. 5-(4-Nitrophenyl)-3-(1H-pyrazol-1-yl)pyrazin-2-amine (1a) 
1-Amino-4-bromo-2-pyrazolopyrazine [16] (200 mg, 0.8 mmol), 
potassium carbonate (460 mg; 3.3 mmol), 4-nitrobenzeneboronic acid 
(167 mg; 1.0 mmol), TBAB (27 mg; 0.083 mmol), Pd(dppf)Cl2 (40 mg; 
0.05 mmol) were placed in a round-bottom flask and solubilized in a 
mixture of dioxane/water (0.5 M; 4/1). The reaction was conducted 
under an argon atmosphere. The mixture was stirred at 100 ◦C for the 
first 6 h and then stirring was continued overnight at room temperature. 
Afterward, the crude mixture was diluted with AcOEt and filtered 
through Celite. The filtrate was concentrated under reduced pressure. 
The crude product was purified by column chromatography on silica gel 
(eluent AcOEt/PE (3/7; 1/1) to obtain the final product 1e - a red solid 
(94 mg, 42 %). 1H NMR (250 MHz, DMSO-d6) δ: 8.91 (d, J =2.6 Hz, 1 H), 
8.82 (s, 1 H) 8.37 (d, J =9.0 Hz, 2 H), 8.29 (d, J =9.1 Hz, 2 H), 7.96 (d, J 
=1.5 Hz, 1 H), 7.91 (s, 2 H), 6.72 (dd, J = 2.7, 1.8 Hz, 1 H). 13C NMR 
(101 MHz, DMSO-d6) δ: 146.7, 146.5, 142.3, 141.4, 138.7, 133.7, 131.6, 
131.1, 129.3, 128.8, 126.0, 124.1, 107.9. HRMS (ESI) for C13H11N6O2 
[M+H]+ found, 283.0938 m/z; calcd mass, 283.0938. Mp: decomposi-
tion over 200 ◦C. 
2.1.3. 2-(4-Nitrophenyl)pyrazolo[1’,2’:1,2][1,2,3]triazolo[4,5-b] 
pyrazin-6-ium-5-ide (1-NO2) 
In a round-bottom flask, 1e (198 mg; 0.7 mmol), (diacetoxyiodo) 
benzene (453 mg; 1.4 mmol;) and sodium hydride (42 mg; 1.7 mmol) 
were dissolved in degassed DMF. The reaction solution was stirred for 6 
h at room temperature. Afterward an extraction of the solution was 
carried out by adding a mixture of DCM/H2O. The aqueous phase was 
washed 3 times with 50 mL of DCM, organic phases were collected, and 
then the solvent was removed on a rotatory evaporator. The crude 
compound was purified on silica gel, eluted with a mixture of AcOEt/PE 
(2/1) and then AcOEt/MeOH (97/3; 92/8), yielding red solid as a 
product (110 mg, 56 %). 1H NMR (250 MHz, DMSO-d6) δ: 9.19 (s, 1 H), 
8.80 (d, J =3.4 Hz, 1 H), 8.53 (d, J =2.6 Hz, 1 H), 8.40 – 8.29 (m, 4 H), 
7.22 (dd, J = 3.4, 2.6 Hz, 1 H). 13C NMR (101 MHz, CDCl3) δ: 149.6, 
146.9, 143.6, 141.8, 134.2, 129.8, 126.3, 124.7, 114.1, 112.5, 111.2. 
HRMS (ESI) for C13H9N6O2 [M+H]+ found, 281.0781 m/z; calcd mass, 
281.0781. Mp: decomposition over 200 ◦C. 
2.1.4. 2-(4-Aminophenyl)pyrazolo[1’,2’:1,2][1,2,3]triazolo[4,5-b] 
pyrazin-6-ium-5-ide (1-NH2) 
Under an argon atmosphere, in a round bottom flask, 1-NO2 (30 mg, 
0.1 mmol) was dissolved in anhydrous THF (5 mL). Pd/C (39 mg) was 
added. Argon was replaced by hydrogen and the reaction mixture was 
stirred under hydrogen atmosphere for 2 h. The suspension was filtered 
through Celite and then column chromatography on silica gel was car-
ried out with AcOEt/MeOH (95/5) as an eluent to give the product 1- 
NH2 as a red solid (16 mg, 59 %). 1H NMR (400 MHz, DMSO-d6) δ: 8.86 
(s, 1 H), 8.58 (d, J =3.4 Hz, 1 H), 8.33 (d, J =2.6 Hz, 1 H), 7.79 (d, J =8.6 
Hz, 2 H), 7.14 (t, J =3.0 Hz, 1 H), 6.67 (d, J =8.9 Hz, 2 H), 5.40 (s, 2 H). 
13C NMR (101 MHz, DMSO- d6) δ: 150.05, 149.16, 138.95, 138.82, 
128.08, 126.64, 123.98, 114.02, 110.96, 110.24, 109.25. HRMS (ESI) 




Under an argon atmosphere, 1-amino-4-bromo-2-pyrazolopyrazine 
[16] (350 mg, 1.5 mmol), 1-ethynyl-4-nitrobenzene (430 mg, 2.9 
mmol) and Pd(PPh3)2Cl2 (105 mg, 0.1 mmol) were solubilized in 
distilled Et3N (5 mL). The mixture was stirred at room temperature for 
20 min and then CuI (25 mg, 0.1 mmol) was added. The solution was 
stirred at 90 ◦C for 2 h. The solvent was removed under vacuum and the 
crude mixture was subjected to column chromatography (EP/AcOEt 7/3 
to 0/1) to give 2e (405 mg, 90 %) as a yellow solid. 1H NMR (250 MHz, 
DMSO-d6) δ: 8.65 (d, J =2.6 Hz, 1 H), 8.34 (s, 1 H), 8.31 – 8.23 (m, 2 H), 
8.04 (s, 2 H), 7.93 (d, J =1.7 Hz, 1 H), 7.88 – 7.79 (m, 2 H), 6.67 (t, J 
=2.2 Hz, 1 H). 13C NMR (101 MHz, DMSO-d6) δ: 146.8, 146.6, 144.8, 
141.5, 132.4, 131.6, 129.2, 128.6, 124.0, 121.0, 108.0, 9.74, 87.7. 
HRMS (ESI) for C15H11N6O2 [M+H]+ found, 307.0940 m/z; clacd mass, 
307.0938. Mp: decomposition over 200 ◦C. 
2.1.6. 2-((4-Nitrophenyl)ethynyl)pyrazolo[1’,2’:1,2][1,2,3]triazolo[4,5- 
b]pyrazin-6-ium-5-ide (2-NO2) 
2e (126 mg; 0.4 mmol), NaH (25 mg; 1.0 mmol), PhI(OAc)2 (265 mg; 
0.8 mmol) were solubilized in degassed DMF (3 mL). The solution was 
stirred for 6 h at room temperature. DCM/H2O extraction was carried 
out and organic phases were collected and concentrated under reduced 
pressure. Purification involved column chromatography on silica gel 
with increasing eluent polarity from AcOEt/PE (1/1) to AcOEt to isolate 
pure 2-NO2 as a product (106 mg, 57 %). 1H NMR (400 MHz, DMSO-d6) 
δ: 8.79 (d, J =3.4 Hz, 1 H), 8.68 (s, 1 H), 8.56 (d, J =2.6 Hz, 1 H), 8.29 
(d, J =8.8 Hz, 2 H), 7.85 (d, J =8.8 Hz, 2 H), 7.23 (t, J =3.0 Hz, 1 H) 13C 
NMR (101 MHz, DMSO-d6) δ: 146.8, 146.7, 132.3, 128.7, 124.0, 120.5, 
114.2, 112.6, 110.8, 92.9, 88.5. HRMS (ESI) for C15H9N6O2 [M+H]+




In a round bottom flask, 2-NO2 (70 mg, 0.2 mmol) was solubilized in 
a mixture of MeOH/H2O (2/1; 7 mL) with the addition of iron powder 
(64 mg, 1.1 mmol) and NH4Cl (123 mg, 2.3 mmol). The mixture was 
stirred mechanically for 36 h. Solvents were removed under vacuum and 
the crude compound was purified by column chromatography (DCM/ 
MeOH 99/1 to 9/1) to give pure 2-NH2 (42 mg, 46 %) as a red solid. 1H 
NMR (400 MHz, DMSO-d6) δ: 8.70 (d, J =3.4 Hz, 1 H), 8.50 (s, 1 H), 8.46 
(d, J =2.6 Hz, 1 H), 7.25 (d, J =8.4 Hz, 2 H), 7.19 (dd, J = 3.4, 2.6 Hz, 1 
H), 6.59 (d, J =8.5 Hz, 2 H), 5.65 (s,2 H). 13C NMR (101 MHz, DMSO-d6) 
δ: 150.3, 149.8, 145.3, 132.6, 128.6, 123.3, 113.7, 112.9, 111.2, 110.5, 
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107.4, 92.2, 84.9. HRMS (ESI) for C15H11N6 [M+H]+ found, 275.1642 
m/z; clacd mass 275.1642. Mp: decomposition over 200 ◦C. 
2.2. General procedure for NTR detection 
The reduction of nitro compounds in the presence of NTR was 
monitored by measuring the emission spectra of the reduced probes 
from 480 to 700 nm upon excitation at 447 nm. Typical conditions 
involved 16 μM of 1-NO2 or 2-NO2, 160 μM NADH, and 2.4 μg/mL NTR 
from Escherichia Coli (Sigma-Aldrich N9284, type I of NTR). The reaction 
was conducted in 50 mM TRIS-HCl buffer pH 7.4 at 37 ◦C. Before each 
measurement, the tested solutions were incubated for 5 min at 37 ◦C, 
followed by the addition of the enzyme. A blank solution with 1-NO2 or 
2-NO2 and NADH in the absence of NTR was also prepared and 
measured under the same conditions. To determine the NTR detection 
limit in the system, fluorescence spectra were measured over time with 
different NTR concentrations (0–7.2 μg/mL). The fluorescence intensity 
at 533 nm was plotted against the concentration of NTR and the 
detection limit was calculated with the following equation: detection 
limit = 3σ/S where σ is the standard deviation of blank measurements 
(based on analyzing 11 samples), S is the slope of the fluorescence in-
tensity vs NTR concentration denoted as a calibration curve. 
2.3. Determination of the reduction products 
The overall reduction of nitro compounds in the presence of NTR was 
monitored by measuring UV–vis spectra. The initial reduction step was 
too fast to be detected by a conventional spectrophotometer, so it was 
followed using an Applied Photophysics stopped-flow SX20 Spectrom-
eter. The evolution of the products was registered with a Perkin Elmer 
HPLC Chromera system equipped with a diode-array detector. A 
Brownlee Validated IBD C18 5 μm, 150 × 4.6 mm column was employed 
for the HPLC separation. Separation method: solvent A: 0.1 M ammo-
nium acetate in water, solvent B: CH3CN; flow rate 1 mL/min; isocratic 
flow 40 % B from 0 to 6 min; gradient from 40 % to 95 % B at 6 min up to 
15 min; isocratic flow 95 % B at 15 min up to 20 min. Chromatograms 
were recorded using absorbance at 447 nm. To identify the products 
resulting from the reduction of 1-NO2 or 2-NO2, LC-HRMS analyses 
were performed on a Bruker maXis (Q-TOF) mass spectrometer coupled 
to a Dionex Ultimate 3000 RSLC system. The chromatographic separa-
tion was performed at 40 ◦C on a Phenomenex Kinetex C18 column (150 
× 2.1 mm; 1.7 μm) with a flow rate of 0.5 mL/min using a gradient of 
water + 0.1 % formic acid (solvent A) and acetonitrile + 0.1 % formic 
acid (solvent B): 3% B from 0 to 0.5 min; 95 % B at 10 min up to 12 min 
and re-equilibration from 12.1 to 15 min. Mass spectra were recorded in 
positive mode using an ESI ion source and the formulas were generated 
using SmartFormula algorithm from DataAnalysis 4.4 software (Bruker) 
with a mass accuracy of 3 ppm. 
2.4. Liver microsomes – source of type II of NTR 
Rat liver microsomes (Sigma-Aldrich M9066) were used as a source 
of type II of NTR. Typical conditions for the reduction involved 16 μM of 
probes, 1 mM of NADH, and 1 mg/mL of liver microsomes, and the re-
action was conducted in 50 mM TRIS-HCl buffer pH 7.4 at 37 ◦C for 3 or 
6 h. The reaction was carried out at air-equilibrated conditions, at 
hypoxia chamber at 1% pO2 as well as in a glovebox (Inert, I-Lab) with 
pO2 content below 1 ppm. The progress of the reduction and reaction 
products was determined using HPLC as described above. 
2.5. Human serum albumin – interference with NTR detection 
The protein stock solution was prepared by dissolving human serum 
albumin (HSA) in water and its concentration was determined spectro-
photometrically from the molar absorptivity of 4.4 × 103 cm− 1 M− 1 at 
280 nm. The influence of HSA on reduction was characterized using size 
exclusion chromatography. Typical conditions involved 16 μM of 1-NO2 
or 2-NO2, 160 μM NADH, 2.4 μg/mL NTR as well as 16 μM HSA, and the 
reaction was conducted in 50 mM TRIS-HCl buffer pH 7.4 at 37 ◦C. After 
1 h of incubation, the reaction mixture was separated by employing 
BioBasic SEC 300 column. Separation method: solvent: 50 mM Tris-HCl 
pH 7.4, 150 mM NaCl, 25 mM NaHCO3; flow rate 0.35 mL/min; time of 
separation 10 min. Chromatograms were recorded using a fluorescence 
detector with λext 490 nm and λem 550 nm. 
2.6. Cell culture conditions 
Biological studies were performed using human highly metastatic 
melanoma A2058 cells line. Cells were cultured in EMEM medium 
supplemented with 2 mM Glutamine, 1% Non-Essential Amino Acids 
(NEAA) (v/v), 10 % Fetal Bovine Serum (FBS) (v/v) and 1% penicillin- 
streptomycin solution (100 units/mL-100 μg/mL) (v/v). Cells were 
routinely cultured at 37 ◦C in a humidified incubator in a 5% CO2 at-
mosphere. Hypoxic conditions were maintained in a humidified hypoxic 
chamber (Coy) filled with a gas mixture comprising 94 % N2, 5% CO2 
and, 1% O2. For hypoxia screens, cells were seeded under normal con-
ditions and then moved to the hypoxic chamber for at least 24 h pre-
incubation. Medium intended to be used in hypoxic experiments was 
also preincubated in the hypoxic chamber for at least 24 h. Alterna-
tively, cells were incubated with 200 μM of desferrioxamine (DFO) 24 h 
before further experiments to chemically induce hypoxia. The experi-
mental conditions for the evaluation of cytotoxicity and photo-
cytotoxicity and the uptake of the studied compounds as well as their 
photostability under in vitro conditions were described in Supplemen-
tary Information. 
2.7. Detection of NTR in cell lysates 
Cells were grown under different conditions (hypoxia, normoxia or 
in the presence of DFO) after 24 h were detached with trypsin, centri-
fuged, counted, and resuspended in lysis buffer (PBS with 1% Triton-X 
100). Lysates were incubated on ice for 30 min and then centrifuged 
at 13,000 rpm for 20 min at 4 ◦C. The supernatant was collected, and the 
protein concentration was determined by Bradford protein assay. 
Human Nitro reductase (NTR) ELISA Kit (MyBioSource.com) was 
applied to evaluate the NTR level in cell lysates according to the man-
ufacturer’s procedure. Experiments were performed in duplicate to get 
the mean values ± standard deviation. 
2.8. Detection of NTR in cell suspensions 
A2058 cells were seeded in a 24-well plate with a density of 3 × 104 
cells per cm2 and kept for 24 h either in normoxia or hypoxic conditions 
and then incubated with 1-NO2 or 2-NO2 (2 μM) for 2 h. Alternatively, 
deferoxamine (200 μM) was added and incubated for 6, 18, or 24 h, to 
cells kept under normoxia for 24 h before this addition and then 1-NO2 
or 2-NO2 (2 μM) were added and incubated for 2 h. Next, cells were 
washed with PBS, detached by trypsin treatment, and analyzed by a BD 
Versa cytometer (λext = 488 nm). 
2.9. Bioimaging of cells 
A2058 cells were seeded on a 96-well plate with a density of 3 × 104 
cells per cm2 and cultured for 24 h in a medium with FBS under nor-
moxic or hypoxic conditions. Next, (still under hypoxic or normoxic 
conditions) the 1-NO2 or 2-NO2 (2 μM) were added and incubated for 2 
h. Afterward the incubated cells were washed with PBS and fluorescent 
images were taken using an Olympus IX83 microscope equipped with a 
CellVivo chamber (λext = 470 ± 20 nm, λem = 525 ± 25). 
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3. Results and discussion 
3.1. Synthesis and photophysical characterization 
We recently synthesized pyridazino-1,3a,6a-triazapentalene deriva-
tive (PyTAP) [16,17] and reported its excellent fluorescent properties. 
Considering its condensed and original mesoionic structure, this scaffold 
was chosen to design a new class of off/on probes for the detection of 
nitroreductase. For this purpose, we conjugated a nitrophenyl moiety as 
the sensitive oxido-reductive group to PyTAP. The reduced counterparts 
with a -NH2 group instead of -NO2 group were also synthesized to 
evaluate photophysical properties of the expected reduced probes. The 
synthetic approach (Scheme 1) was based on the intramolecular metal 
free N–N bond formation from pyridazinyl amines through the forma-
tion of an electrophilic nitrenium species [16]. Starting from bromoa-
minopyrazine [16], we first introduced the nitrophenyl moieties 
through a Suzuki cross-coupling reaction with the 4-nitrophenyl boronic 
acid to obtain 1a and through a Sonogashira cross-coupling reaction 
with 4-nitrophenylacethylene to obtain 2a (Scheme 1). The key N–N 
bond formation was then conducted in the presence of PhI(OAc)2, NaH 
in DMF which efficiently formed compounds 1-NO2 and 2-NO2 thanks 
to the favorable electron-withdrawing character of the nitro group in 
this nitrene mediated cyclization. 
The 1-NO2 and 2-NO2 probes were designed to act as the “switch off” 
forms, and the reduced forms 1-NH2 and 2-NH2 as the “switch on” 
forms. Their synthesis involved the reduction of the nitro group by the 
application of two different reaction conditions. The para-nitrophenyl 
PyTAP derivative (1-NO2) was reduced under hydrogen in the presence 
of Pd/C to obtain 1-NH2, while the para-nitrophenyl alkyne derivative 
(2-NO2) required selective reduction conditions for the NO2 group in the 
presence of iron and NH4Cl to successfully yield 2-NH2 as the final 
product. 
The photophysical data for all synthesized compounds with the 
PyTAP reference (i.e. unsubstituted pyridazino-1,3a,6a-triazapentalene) 
are collected in Table 1, while their absorption and emission spectra are 
shown in Fig. A1. For nitro-PyTAP’s derivatives, negligible fluorescence 
was determined due to effective quenching of fluorophore by the 
nitroaromatic group, which was previously observed for many other 
compounds [18]. Interestingly, the corresponding amine-derivatives 
1-NH2 and 2-NH2 exhibited intense fluorescence with a very high 
quantum yield of 0.76 and 0.50 in DMSO, respectively. The fluorescence 
of 1-NH2 and 2-NH2 in an aqueous solution was very low, with a 
quantum yield below 0.2 % (Table S1). Such quenching effect of water is 
well recognized [19] and reported for PyTAP derivatives [17]. 
Table 1 
Spectroscopic properties for the triazapentalene compounds in DMSO.   
Absorption Emission 
λmaxa [nm] ε [M− 1 cm− 1] λmax [nm] ϕb τ[ns] 
1-NO2 466 17900 541 0.0005 – 
1-NH2 468 18200 546 0.76 6.65 
2-NO2 465 14500 541 0.00015 – 
2-NH2 464 17200 542 0.50 6.67 
PyTAP 418c 15500c 516c 0.15c –  
a Maximum of absorption band in visible region of spectrum. 
b ϕ is the relative fluorescence quantum yield determined using [Ru(bpy)3]Cl2 
(ϕ = 0.028 in H2O) as a reference standard. 
c Data taken from reference [17]. 
Fig. 1. A) Photostability of 1-NH2 and 2-NH2 dissolved in TRIS-HCl buffer (pH 7.4, 50 mM) monitored by registration of changes in absorption (447 nm) and 
fluorescence (λex = 447 nm, λem = 564 nm) after irradiation at 465 nm. B) Photostability in vitro of 1-NH2 and 2-NH2 tested on A2058 cell line and monitored by 
registration of changes in fluorescence intensity (λex = 447 nm, λem = 530 nm) after irradiation at 465 nm. The concentration of the compound 40 μM. 
Fig. 2. Fluorescence emission spectra (λex = 447 nm) of 16 μM 1-NO2 (black 
line) and 2-NO2 (blue line)) before (dash line), and after (solid line) the reac-
tion with nitroreductase (2.4 μg/mL) taking place in the presence of 160 μM 
NADH for 15 min in air-equilibrated conditions. The red line denotes the 
reduction of 2-NO2 under deoxygenated conditions. Inset: The corresponding 
time-dependent changes of fluorescence intensity (FI) at 532 nm. TRIS-HCl 
buffer (pH 7.4, 50 mM), 37 ◦C. (For interpretation of the references to colour 
in this figure legend, the reader is referred to the web version of this article). 
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Importantly, the emission of 1-NH2 and 2-NH2 was not quenched by 
molecular oxygen neither in the aqueous solutions nor in DMSO 
(Fig. A2), making their fluorescence independent of oxygen. A signifi-
cant advantage of both probes was, that their amine derivatives were 
very stable upon irradiation in TRIS buffer, and only a slight decom-
position was observed for 1-NH2 (Fig. 1A). 
3.2. Probes response to nitroreductase 
In these studies, type I oxygen-insensitive NTR from Escherichia coli 
encoded by the NfsB gene was used to evaluate the response of 1-NO2 
and 2-NO2 probes. Both probes exhibited almost no fluorescence emis-
sion upon excitation at 447 nm, however, time-dependent fluorescence 
enhancement was observed after their co-incubation with NTR and 
NADH (Fig. 2). As was determined, NADH alone was not able to reduce 
the tested compounds (Fig. 4). Furthermore, a gradual concentration- 
dependent decrease in fluorescence intensity caused by dicoumarol 
(Fig. A3), a competitive inhibitor of NADH [20], proved that the fluo-
rescence off-on response of 1-NO2 and 2-NO2 with regard to NTR was 
directly related to its enzymatic activity. 
The reduction of both probes led to the formation of products with a 
clear emission maximum at 532 nm and an enhancement of fluorescence 
intensity by more than 15-fold. As expected, for type I NTR, which 
catalyzes the reduction of the nitro group by the addition of a pair of 
electrons independent of the presence of the molecular oxygen [10], the 
first steps of the reduction in deoxygenated conditions were similar to 
the observed for the reaction carried out in air-equilibrated conditions 
(Fig. 2). A relatively fast and gradual increase of the emission intensity 
was observed within the first 10− 15 min (insets in Figs. 2 and A4). 
Time-dependent absorption spectra showed that the reduction pro-
ceeded in several steps (Figs. A5–A7) as was also confirmed by the 
corresponding chromatograms (Fig. S8). The HRMS analysis of the 
samples (see Table A2) pointed out that under air-equilibrated condi-
tions the nitroso derivatives of both probes along with azoxy dimers 
were the predominant products, as is depicted in Scheme A1. The for-
mation of such dimers from nitroso compounds was previously observed 
for other nitroarenes [21,22]. The studied samples also contained small 
amounts of the amine counterparts (1-NH2 and 2-NH2) as well as traces 
of the hydroxylamine derivatives, which are unstable under experi-
mental conditions and thus undergo re-oxidation to nitroso derivatives 
by molecular oxygen. The reduction of nitroso compounds to their hy-
droxylamine counterparts was continued until the complete depletion of 
NADH occurred. NADH was introduced to the reactions in 10-fold excess 
over 1-NO2 or 2-NO2 probes. Since the evolution of the reaction 
Scheme 2. Major (green circle) and minor products of the 1-NO2 and 2-NO2 probes reduction in the presence of type I nitroreductase under air-equilibrated 
conditions. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article). 
Fig. 3. A) Time-dependent changes of fluorescence intensity (λex = 447 nm, λem = 533 nm) of 2-NO2 (16 μM) in the presence of various concentrations of NTR (0.2 – 
7.2 μg/mL) in the presence of 160 μM NADH, TRIS-HCl buffer (pH 7.4, 50 mM), 37 ◦C; B) A correlation between fluorescence intensities and concentrations of NTR 
after 15 min reaction. 
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products was oxygen-dependent, when the reaction was carried out 
under argon, the depletion of NADH was much slower due to a limited 
excess of oxygen, which resulted in suppressing the re-oxidation reac-
tion (Fig. A7). The reactions taking place in the investigated system were 
schematically presented in Scheme 2. 
The fluorescence of 1-NO2 and 2-NO2 was gradually enhanced with 
increasing concentration of NTR and a good linear correlation was 
achieved in the concentration range of 0− 4 μg/mL (Figs. 3 and A9). The 
calculated detection limit was as low as 18.6 and 33.2 ng/mL of NTR for 
1-NO2 and 2-NO2, respectively, according to the 3σ/S standard (σ - 
standard deviation of blank measurements, S – a slope of calibration 
curve). 
Furthermore, as shown in Fig. 4 the response of the 1-NO2 and 2-NO2 
probes to NTR was not affected by different classes of compounds 
occurring in the intracellular environment, including low molecular 
weight biological reductants (NADH, GSH, vitamin C, Cys) or oxidants 
(H2O2), inorganic salts (NaCl, KCl, CaCl2, MgCl2), amino acids (Arg, 
Lys), glucose or other enzymes with the potential to reduce the nitro 
group (xanthine oxidase) [23]. The obtained data pointed out that the 
designed compound might be considered a sensitive and selective probe 
for the determination of NTR. 
Liver microsomes were used as a source of mammalian nitro-
reductases, belonging mainly to the type II of NTRs, which are oxygen- 
sensitive [9]. The 2-NO2 probe was incubated with microsomes in the 
presence of NADH for 6 h under different oxygen concentrations. The 
reduction progress was monitored using HPLC and a plate reader as well 
(Figs. 5 and A8C). The obtained data revealed that the fully reduced 
product 2-NH2 was only obtained when the reaction was carried out at a 
very low oxygen concentration (either <1 ppm of pO2 when kept in a 
glovebox or 1% pO2 when kept in a hypoxia chamber) while no reduced 
product was observed at air-equilibrated conditions (Fig. 5A). The 
emission from microsomes incubated with 2-NO2 and NADH registered 
using a plate reader was higher when the reduction was performed 
under hypoxic conditions (Fig. 5B). The observation of fluorescence 
under both conditions suggests that the formed nitroso and hydroxyl-
amine intermediates can interact with proteins present in microsomes 
and this interaction can result in fluorescence enhancement (a similar 
effect was observed in the presence of HSA as discussed in the next 
section). Only under oxygen-deprived conditions, the reduction pro-
ceeds readily enough to get fully reduced products, which can be 
Fig. 4. Fluorescence intensity at 538 nm (λex = 447 nm) of 5 μM 1-NO2 (A) and 2-NO2 (B) in solution on its own and in the presence of various reductants: NADH 
(150 μM), GSH (1 mM), Vitamin C (1 mM), Cys (1 mM); oxidant H2O2 (1 mM); salts: NaCl (1 mM), KCl (1 mM), CaCl2 (1 mM), MgCl2 (1 mM), amino acids: Arg (1 
mM), Lys (1 mM); glucose (1 mM); xanthine (150 μM) with xanthine oxidase (XO, 0.01U/mL); NADH (150 μM) with xanthine oxidase (0.01U/mL) – grey bars, and 
NADH (150 μM) with nitroreductase (NTR, 2.4 μg/mL) – black bar. All data were collected 30 min after mixing of reagents and incubation at 37 ◦C. 
Fig. 5. A) Comparison of chromatograms obtained for reduction products of the 2-NO2 probe (16 μM) incubated with NADH (1 mM) and microsomes (1 mg/mL) for 
6 h under normoxia (21 % pO2), hypoxia (1% pO2), or in the anaerobic environment (< 1 ppm of pO2, denoted as ~0% pO2). Chromatograms were recorded using 
absorbance at 447 nm. B) The emission spectra (λext = 466 nm) of microsomes on their own (blank) and after 6 h following the addition of 2-NO2 (16 μM) and NADH 
(1 mM) kept under normoxic or anaerobic conditions. Experimental conditions: 50 mM TRIS-HCl buffer pH 7.4, 37 ◦C. 
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separated from the protein fraction using HPLC. Collected data strongly 
supports the relevance of the designed probes in the evaluation of NTR 
overexpressed in cancer cells (typically type II), the activity of which is 
strongly related to the presence of oxygen. We believe that fluorescent 
products generated after the accumulation of probes in hypoxic cells can 
be further examined in air-equilibrated conditions, typically encoun-
tered when using either a plate reader or flow cytometry, since the 
reduction of these probes will be halted under such conditions. This 
leads to avoiding the false positive effect and was confirmed by us in in 
vitro studies (vide infra). 
3.3. Human serum albumin – interference with NTR detection 
The fluorescence of the studied probes and their reduced counter-
parts was markedly enhanced by the presence of human serum albumin 
(HSA) in a concentration-dependent manner (see Fig. A10). The increase 
in emission correlated well with the association constant value for the 
formation of the studied compound-HSA adducts (see Fig. A11 and 
Table A3). Presumably, the binding of the studied compounds to HSA 
results in their protection from external water molecules, thus pre-
venting their quenching [19]. Also, the dielectric constant in the protein 
environment is much lower than in water [24], which is associated with 
an increase in the quantum yield of fluorescence. Converting compounds 
that are not fluorescent in an aqueous solution into highly emissive ones 
in the presence of HSA was previously reported for other fluorophores 
[25]. Similar protein-induced fluorescence enhancement (PIFE) effects 
were observed for carbocyanine dyes linked covalently to DNA, for 
which the fluorescence intensity greatly increased when a protein was 
bound in its proximity [26]. 
HSA can interfere not only with the bioavailability of the probe but 
also with its response to NTR. Therefore, the activity of NTR was also 
checked in the presence of HSA by the application of size exclusion 
chromatography (Figs. 6 and A12). HSA was eluted after 4.82 or 5.06 
min as recorded by DAD (280 nm) or fluorescence (λext = 490 nm, λem =
550 nm) detector, respectively. The longer retention time was assigned 
to low-molecular-weight compounds, in particular to NADH. As clearly 
shown in Figs. 6 and A12B the NTR can reduce both probes in the 
presence of HSA, however, only in the case of 2-NO2 a pronounced 
enhancement in the fluorescence was observed. The reduction of the 
nitro group was slower than in the absence of the protein, which can 
arise from worsened access of the enzyme to the nitro moiety. Under the 
experimental conditions, there was a gradual increase in the observed 
emission even up to 24 h during the incubation with NTR in the presence 
of HSA, while in the absence of the protein the reaction was over after 
0.5 h. The fluorescence signal depends on both the NTR concentration 
and the time of incubation (Fig. A12C). To the best of our knowledge, 
this report is the first to demonstrate the effect of HSA on the effec-
tiveness of an NTR probe. The results show that binding the probes to the 
protein does not inactivate them. 
3.4. In vitro toxicity and photostability of probes – normoxic and hypoxic 
conditions 
The highly metastatic human melanoma cell line A2058 was selected 
to assess the in vitro properties of both probes. It is known that in mel-
anoma, hypoxia is quite common and is responsible for drug resistance. 
Moreover, there is a strong correlation between hypoxia and poor pa-
tient prognosis, as well as tumor metastasis [27]. In these studies, in vitro 
experiments were carried out on cells, which were grown in normoxic 
conditions (21 % pO2), hypoxic conditions using a hypoxic chamber (1% 
pO2) as well as in the presence of a chemical, hypoxia-inducing agent 
desferrioxamine (DFO), which was used to mimic hypoxia in normoxic 
conditions. DFO, the iron chelator can induce accumulation of the 
hypoxia-inducible factor-1alpha (HIF-1α) protein, which is a regulator 
of the cellular response for hypoxia [28,29]. All studied compounds 
were neither cytotoxic nor photocytotoxic, and the viability of the cells 
was not disturbed even up to 64 μM concentration of the compounds 
(Figs. A13–A14). Both amine derivatives were photostable after accu-
mulation in cells, and the degradation was less than 20 % after pro-
longed irradiation (Fig. 1B). The absence of photobleaching of potential 
NTR activity products in the cellular microenvironment enables the 
long-term observation of probes applying an even higher lamp intensity. 
Fig. 6. Size exclusion separation of 16 μM human serum albumin (HSA) 
incubated in the presence of 16 μM 2-NO2, 160 μM NADH, 2.4 μg/mL NTR or 
their mixtures during 1 h. Chromatograms were recorded using a fluorescence 
detector with λext = 490 nm and λem = 550 nm. Experimental conditions: TRIS- 
HCl buffer (pH 7.4, 50 mM), 37 ◦C. 
Fig. 7. NTR expression in A2058 cells measured by ELISA after they were 
exposed to normal (normoxia, 21 % of pO2) and decreased (hypoxia, 1% of 
pO2) oxygen concentration or incubated with 200 μM desferrioxamine (DFO) 
for 24 h under normoxia. 
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3.5. Detection of nitroreductase in cells 
As far as we know, the expression of nitroreductase in A2058 cells 
has never been assessed. In this study, the amount of NTR was 
determined in cell lysates using a commercially available human 
nitroreductase ELISA kit. All cells were lysed after 24 h of growth under 
normoxic (21 % pO2) conditions in the absence and presence of 200 μM 
DFO (desferrioxamine) as well as under hypoxic (1% pO2) conditions. As 
Fig. 8. Relative fluorescence intensity from 1- 
NO2 and 2-NO2 (2 μM) incubated for 2 h with 
A2058 cells under decreased oxygen concen-
tration (1%) or with cells pre-incubated with 
200 μM desferrioxamine (DFO) for 24 h under 
normoxia (21 %) compared to cells kept under 
normoxia determined using flow cytometry. In 
circles: direct data from the cytometer (black – 
control cells, red – cells under normoxia, green 
– cells incubated with 200 μM DFO for 24 h, 
blue – cells under hypoxia). (For interpretation 
of the references to colour in this figure legend, 
the reader is referred to the web version of this 
article).   
Fig. 9. Fluorescence images of A2058 cells cultured under normoxic (21 % pO2) and hypoxic (1% pO2) condition 24 h prior treatment with 1-NO2 or 2-NO2 (8 μM) 
for 2 h. 
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shown in Fig. 7, A2058 cells produced NTR under normoxia, and its 
amount increased almost twofold when they were cultured in hypoxic 
conditions. The amount of NTR was also elevated when hypoxia was 
chemically induced by DFO, but the increase was smaller. This data 
confirms that hypoxia can lead to the enhancement of NTR expression in 
A2058 cells. 
The applied ELISA kit involved the lyses of cells, while the 1-NO2 and 
2-NO2 probes were designed to identify the changes associated with the 
hypoxic conditions in the intact cells using either a plate reader or a flow 
cytometer. Both probes accumulated in A2058 cells quickly and effi-
ciently, and their levels remained unchanged for the first hour 
(Fig. S15). A pronounced increase in fluorescence intensity of cells was 
detected after 2 h of incubation, and it can be derived not only from the 
accumulation of probes, but also their conversion catalyzed by NTR. 
Therefore, for further experiments, 2 h were chosen as an optimal in-
cubation time. Incubation of cells with 2-NO2 resulted in the detection 
of a significantly higher fluorescence signal than for 1-NO2, which can 
be a result of protein-induced fluorescence enhancement effect observed 
predominately for 2-NO2 in the presence of albumin. 
To test the effectiveness of both sensors i.e. 1-NO2 and 2-NO2 in 
distinguishing between cells cultured under hypoxic and normoxic 
conditions, probes were incubated with cells for 2 h. Then, cells were 
washed with PBS buffer, detached using trypsin, resuspended in PBS, 
and analyzed using a flow cytometer. As shown in Fig. 8 there was a 
clear difference between cells grown in normoxia compared to those 
cultured under hypoxia. The fluorescence intensity markedly increased 
along with the decline of oxygen concentrations and the obtained results 
pointed out that the reduction of both probes is the reaction responsible 
for the observed signals. It must be noted that upon excitation at 488 nm 
the emission from cells can be detected at different channels: FITC (488/ 
527 ± 16 nm), PE (488/586 ± 21 nm), or PerCP (488/700 ± 27 nm) due 
to sufficient emission even at longer wavelengths (see Fig. A16). This 
allows minimizing the autofluorescence effect from cells. Furthermore, 
the application of DFO as a chemical inducer of hypoxic conditions led 
to lower fluorescence intensity, but it was still clearly distinguishable 
from cells growth in normoxia. This effect was time-dependent 
(Fig. A17) and showed that 6 h incubation with DFO was not enough 
to induce hypoxia in cells. The reduction of probes underwent under all 
studied conditions, however, it was more pronounced under hypoxic 
conditions due to the overexpressing of reductase enzymes by cells [7] 
as a response to hypoxia. As we showed in Fig. 7 NTR was overexpressed 
under such conditions in A2058 cells, and this enzyme of either Type I or 
Type II can readily reduce the studied probes. The designed probes allow 
for a fast assessment of the difference in NTR content for various cell 
samples without the need for specialized sample preparation. 
3.6. Bioimaging applications 
A2058 cells incubated with both probes under normoxic conditions 
showed week fluorescence, while cells treated with the same amount of 
1-NO2 or 2-NO2 and cultured under hypoxia prior to the treatment 
exhibited very bright emission (Fig. 9). It is direct evidence that fluo-
rescence is turned on under hypoxic conditions. This data is a good 
illustration of the more accurate and sensitive measurements that were 
made with a flow cytometer (Fig. 8) or a plate reader (Fig. S18). In 
addition, we expect that the observed difference will be large enough to 
visually compare two tissues with different NTR activity using a fluo-
rescence microscope. Further in vivo studies are needed to evaluate 
whether the detection of endogenous NTR by both probes can be 
correlated with the occurrence of hypoxia and whether 1-NO2 and/or 2- 
NO2 probes can be applied to monitor the hypoxic status of tumor cells. 
4. Conclusions 
The major outcomes of the investigated probes are schematically 
presented in Chart 1 . The obtained results clearly showed that the nitro- 
pyrazinotriazapentalene derivatives were reduced by both types of NTRs 
and generated highly fluorescent products. The reaction was sensitive, 
elective and the formation of products is directly proportional to the 
amount of the enzyme, with a detection limit as low as ca. 20− 30 ng/mL 
of NTR. For oxygen-sensitive NTR present in microsomes, hypoxic 
conditions allowed a complete reduction of the nitro derivative to its 
amine counterpart, which was not observed under normoxic conditions. 
Furthermore, the in vitro studies showed that probes readily accumu-
lated in cells without exhibiting host cell toxicity in the concentration 
range necessary for their application. The obtained data clearly indicates 
that endogenous NTR is related to hypoxic conditions and the investi-
gated probes were able to evaluate the hypoxia status in tumor cells. It 
was shown that quantification of hypoxia in cells can be achieved with 
the use of a plate reader or flow cytometry or can be assessed visually by 
imaging cells using fluorescence microscopy. The last approach may be 
helpful in the comparison of tissues collected during a tumor biopsy; 
however, further in vivo studies are needed to support this claim. In the 
context of in vivo tests, it is promising that HSA does not inactivate the 
reduction of the probes, and the presence of proteins may enhance the 
fluorescence intensity, which will allow the use of smaller probe 
concentrations. 
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Scientific Research. His current research interests are focused on various aspects of mass 
spectrometry hyphenated with separation techniques. 
Marie-Aude Hiebel obtained her Doctor Degree in organic chemistry from Claude Ber-
nard Lyon 1 University in 2008. Now she is an assistant Professor in Institut de Chimie 
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